Deborah Gilbert

Dose ranging and fractionation of intravenous ciprofloxacin against Pseudomonas aeruginosa and Staphylococcus aureus in an in vitro model of infection

C. Randall Marchbanks, Joan R. McKiel, Deborah Gilbert et al. · Antimicrobial Agents and Chemotherapy · 1993 · 65 citations · Full text

Staphylococcus Aureus, Antimicrobial Chemotherapy, Antibiotic Resistance +18

Pharmacodynamics of piperacillin alone and in combination with tazobactam against piperacillin-resistant and -susceptible organisms in an in vitro model of infection

Andy H. Strayer, Deborah Gilbert, P Pivarnik et al. · Antimicrobial Agents and Chemotherapy · 1994 · 51 citations · Full text

Antibiotic Adjuvant, Antimicrobial Chemotherapy, Antibiotic Resistance +16

Combination Therapy with Ciprofloxacin plus Azlocillin against Pseudomonas aeruginosa: Effect of Simultaneous versus Staggered Administration in an In Vitro Model of Infection

Michael N. Dudley, J. Blaser, Deborah Gilbert et al. · The Journal of Infectious Diseases · 1991 · 44 citations · Full text

Predictors of Effect of Ampicillin-Sulbactam against TEM-1 β-Lactamase-Producing <i>Escherichia coli</i> in an In Vitro Dynamic Model: Enzyme Activity versus MIC

Alexander A. Firsov, Danièle Saverino, Matthew Ruble et al. · Antimicrobial Agents and Chemotherapy · 2006 · 40 citations · Full text

Escherichia Coli, Disc Susceptibility, Antibiotic Resistance +16

Selection of linezolid-resistant Enterococcus faecium in an in vitro dynamic model: protective effect of doxycycline

Stephen H. Zinner, Deborah Gilbert, Irene Yu Lubenko et al. · Journal of Antimicrobial Chemotherapy · 2008 · 34 citations · Full text